Group 1: During 12 weeks: BEV (adaptive Balance movements, Eye-movements and Visual stimulation exercises), (ii) health education (HE) and (iii) CBT (cognitive behavioral therapy), (iv) MC: Medical Co
Sponsors
Clinical Research OrganizationHP Zenner Clinical GmbH&CoKG, Digitineers GmbH und Co KG
Conditions
H81H81.0
H81.1
H81.2
H81.3
H81.8
H81.9
R29.6
Unknown Phase
Prospective Randomized Group Controlled Study of Clinical Efficacy and Safety of the CE marked Vertidisan® App
Active, not recruitingDRKS00024188
Start: 2022-10-10Target: 200Updated: 2025-04-07
Prospective Randomized Group Controlled Multicenter Study
of Clinical Efficacy and Safety of VH90D
Active, not recruitingDRKS00028026
Start: 2022-10-10Target: 220Updated: 2025-10-06